{"id":"W2551958233","doi":"10.1016/j.jaad.2016.09.026","title":"Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Etanercept; Psoriasis; Adverse effect; Clinical trial; Incidence (geometry); Internal medicine; Psoriatic arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001351531,0.0002316737,0.002203595,0.0001655193,0.0000640787,0.000007298832,0.0006693277,0.0002508809,0.0000428461],"category_scores_gemma":[0.0007896331,0.0001026817,0.0001667435,0.0001551549,0.001434971,0.000153366,0.0002507714,0.0004953491,0.000004401299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002401266,"about_ca_system_score_gemma":0.00009190587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003500333,"about_ca_topic_score_gemma":0.00006193023,"domain_scores_codex":[0.9943784,0.00329538,0.001717939,0.0002894405,0.00006714612,0.000251715],"domain_scores_gemma":[0.9938192,0.00399724,0.001787548,0.0003025795,0.00003713708,0.00005626499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002760742,0.0001306828,0.8699359,0.000005040214,0.001355983,0.00002401676,0.0000743901,1.84488e-7,0.003045535,0.00002856588,0.001053017,0.1215859],"study_design_scores_gemma":[0.005061734,0.0001816337,0.9883423,0.0001541278,0.0007597252,0.001564882,0.0002098535,0.00000138431,0.001599205,0.00005096258,0.001940964,0.0001332642],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843718,0.004011556,0.0002311274,0.01068231,0.0002623613,0.0001698348,0.0002554174,0.000007565797,0.000008040933],"genre_scores_gemma":[0.9953821,0.003773806,0.0003969923,0.0003530857,0.00003482974,0.000002255068,0.00001372378,0.00001288778,0.00003033793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1214527,"threshold_uncertainty_score":0.5287209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.112103159361773,"score_gpt":0.3928063394197767,"score_spread":0.2807031800580038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}